Cathflo Activase (Genentech, Inc.)
Welcome to the PulseAid listing for the Cathflo Activase drug offered from Genentech, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | Alteplase |
| SUBSTANCE NAME: | ALTEPLASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2001-09-04 |
| END MARKETING DATE: | 0000-00-00 |
Cathflo Activase HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cathflo Activase from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.2(mg/2mL) |
| START MARKETING DATE: | 2001-09-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-041_162fe6a5-4dc6-46b5-8206-24a0af55f2d1 |
| PRODUCT NDC: | 50242-041 |
| APPLICATION NUMBER: | BLA103172 |
Other ALTEPLASE Pharmaceutical Manufacturers / Labelers:
